Illumina

Senior / Staff Software Engineer

Singapore, Singapore, Singapore

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Genomic Technology, Biotechnology, HealthcareIndustries

Requirements

Candidates should possess a Bachelor’s or Master’s degree in computer science or engineering, and demonstrate strong experience in object-oriented programming, particularly with C#, along with the ability to design, develop, and maintain robust, unit-tested .NET applications. They must also have proficiency in source control management (GIT, SVN), experience with CI/CD, and a self-starter mentality with excellent communication and problem-solving skills, thriving in a fast-paced environment. Experience in instrument software/hardware integration, biotechnology, bioinformatics, or image processing is considered a plus.

Responsibilities

The Senior/Staff Software Engineer will work as part of Agile scrum teams to design, implement, and test the instrument control software for Illumina’s DNA sequencing and genotyping devices, contributing to software architecture and designs. They will participate in all stages of the agile development process, including sprint planning, daily scrum meetings, and demos, while creating and executing unit tests, troubleshooting defects, and contributing to design and code reviews. Furthermore, they will deliver complex technical information clearly and concisely, and collaborate across organizations.

Skills

C#
Object-Oriented Programming
.NET
Multi-threading
Agile
Scrum
Unit Testing
Software Design
Code Reviews
Problem-Solving
Troubleshooting
Communication

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI